Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Mirati Therapeutics Promotes Chief Financial Officer

Mirati Therapeutics, a targeted oncology company based in San Diego, California, has promoted Vice President of Finance Jamie A. Donadio to Senior Vice President and Chief Financial Officer. In his new role, Donadio will be responsible for all corporate finance … Continue reading

Posted in Executive Appointments | Tagged , , | Leave a comment

Rigel Appoints Chief Medical Officer

Rigel Pharmaceuticals, a clinical-stage biotechnology company focused on immunology, oncology and immuno-oncology, has appointed Anne-Marie Duliege as chief medical officer to replace Elliott Grossbard, who is to retire after 14 years of service. Grossbard will remain with the company, advising … Continue reading

Posted in Executive Appointments | Tagged , , | Leave a comment

PsiOxus Therapeutics Elects Paolo Paoletti as Chairman of the Board

PsiOxus Therapeutics, an immuno-oncology company in Oxford, England, has appointed Paolo Paoletti to Chairman of its Board to replace Michael Moore. Moore will remain on the Board as Deputy Chairman. “I am certain that Paoletti’s proven experience in oncology drug … Continue reading

Posted in Board Director Appointments | Tagged , , , , , , , , , , , | Leave a comment

Xencor adds Board Director with ex-Flexus executive

Xencor, Inc., a clinical-stage biopharmaceutical company based in California which is developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, have appointment Yujiro S. Hata to its board of directors. “Yujiro’s wealth of … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , | Leave a comment

CTI BioPharma hires a Chief Commercial Officer

Previously names Cell Therapeutics now CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) have appointment Bruce Seeley as Executive Vice President and Chief Commercial Officer, reporting to James Bianco, M.D., CTI BioPharma’s President and Chief Executive Officer. Seeley joins … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , | Leave a comment

Hans Schikan appointed Chairman of Complix

Complix, a biopharmaceutical company focused on developing a pipeline of transformative protein therapeutics, called Alphabodies™, mainly focused on oncology and autoimmune diseases, today announced the appointment of Hans Schikan as Chairman of its Board of Directors.   Hans Schikan has more than … Continue reading

Posted in Executive Appointments | Tagged , , , , , , , , , , , , , , , | Leave a comment

Sutro Biopharma signs $1bn deal with Celgene

Authored by James Sheppard The San Francisco based biotech company Sutro Biopharma announced that it has signed a multi-year strategic collaboration and option to acquire agreement with the global biotech company Celgene. The deal follows an agreement signed between the … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , | Leave a comment

Genentech pays $150m for NewLink’s oncology drug

Authored by James Sheppard Global biotech giant Genentech, part of Roche, announced a partnership with Iowa based biotech company NewLink Genetics. The partnership could be worth in excess of $1bn for NewLink if there assets hit certain predefined milestones. Genentech … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , | Leave a comment

Raze Therapeutics raises $24m in Series A funding

Authored by James Sheppard The venture capital giant Atlas Ventures announced that it has launched a newly formed biotech called Raze Therapeutics. Raze will be based in the Boston Biotech Cluster. Atlas was not alone in funding the company and … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Oslo Cancer Clusters Biotech Ambition: The Strategic Vision

Authored by Karl Simpson Oslo, Norway is not everyone’s immediate response when asked for their view of an emerging biotech cluster with international prominence. Norway, a country with rich resources and an economy which has been benefiting from the considerable … Continue reading

Posted in Executive Appointments, M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap